世界のインポテンス治療薬市場 – 業界動向と2029年までの予測

インポテンス治療薬市場の分析と規模

世界のインポテンス治療薬市場は、予測期間中に大幅な成長が見込まれています。動脈硬化、高血圧、糖尿病、肥満、うつ病、ストレス、その他の病状など、勃起不全を引き起こす可能性のある多くの理由も、世界のインポテンス治療薬市場を後押しするでしょう。インポテンス治療薬の投与後の副作用は、インポテンス治療薬市場を妨げる可能性があります。COVID-19も市場の成長に大きな影響を与えました。

データブリッジ市場調査は、2022年から2029年の予測期間における世界のインポテンス治療薬市場の成長率を分析しています。世界のインポテンス治療薬市場の予想CAGRは、前述の予測期間中に約7％になる傾向があります。市場は2021年に36億米ドルと評価され、2029年までに61億9000万米ドルまで成長すると予想されています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、データブリッジ市場調査チームがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

市場の定義

インポテンス治療薬は、男性の勃起不全を治療し、性交回数を増やすために使用されるタイプの薬です。これらの薬は一般的に血管拡張と男性生殖器への血流を増加させ、勃起を引き起こします。これはヘルスケア分野にとって非常に重要になってきており、今後拡大することが期待されています。

インポテンス治療薬市場の範囲とセグメンテーション

Global Impotence Agents Market Dynamics

Drivers

• Increased Incidence of Erectile Dysfunction

Increasing prevalence of erectile dysfunction are expected to boost the market growth over the forecast period 2022-2029. For instance, according to the World Health Organization (WHO) reports, approximately 150 million people are affected by erectile dysfunction globally, and the number is expected to reach 230 million by 2025. Erectile Dysfunction is a  common medical condition affecting about 15% of men annually. Thus, it boosts market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to prompt the market growth. The segment is expected to boost the global market as most products are available in capsule and tablet form and it is a very suitable route of administration.

Opportunities

• Increasing Demand for Retail Pharmacies

The rise in the number of impotence agents delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Risk of Side-Effects

The varied side-effects associated with impotence agents could curb the growth of the global PDE inhibitors market over a forecast period. Side-effects such as dyspepsia and headache, and to a lesser extent, myalgia, low-back pain, flushing, and rhinitis are visible with the use of impotence agents.

• High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global impotence agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global impotence agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Impotence Agents Market            

COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term consequences are expected to boost the industry growth during the forecast period. The shift of healthcare infrastructure towards managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

In the post-pandemic era, changes are witnessed in use of different inhibitors. Socioeconomic stressors have also increased the demand for these drugs. Thus, this will leave a significant impact on the global impotence agents market.

Global Impotence Agents Market Scope

The global impotence agents market is segmented on the basis of product, indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Erectile Dysfunction
• Others

Product

• Tablets
• Injections
• Urethral Suppository
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Impotence Agents Market Regional Analysis/Insights

The global impotence agents market is analysed and market size insights and trends are provided by product, indication, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global impotence agents market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global impotence agents market throughout the forecasted period due to increasing hypertension and diabetes patients and increased prevalence of erectile dysfunction in males.

North America dominates the market due to increasing initiatives taken by the pharmaceutical organizations to generate novel formulations.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Impotence Agents Market Share Analysis

世界のインポテンス治療薬市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータポイントは、世界のインポテンス治療薬市場に関連する企業の焦点にのみ関連しています。

世界のインポテンス治療薬市場で活動している主要企業は次のとおりです。

• ファイザー社（米国）
• マイランNV（米国）
• ノバルティスAG（スイス）
• ヒクマ・ファーマシューティカルズ（英国）
• オーロビンドファーマ（インド）
• アッヴィ社（米国）
• メリンタ・セラピューティクス（米国）
• ヤンセン・グローバル・サービス LLC (米国)
• ブリストル・マイヤーズスクイブ社（米国）
• GSK plc. (英国)
• バイエルAG（ドイツ）
• テバ・ファーマシューティカルズ・インダストリーズ社（イスラエル）
• リリー（米国）
• アストラゼネカ（インド）

SKU-54079